OA10133A - Inhibition of retrovirus infection - Google Patents

Inhibition of retrovirus infection Download PDF

Info

Publication number: OA10133A
Authority: OA; OAPI
Prior art keywords: cys; pro; lys; gly; slpi
Prior art date: 1992-09-09

Application number

OA60622A

Other languages

English (en)

Inventor

Stephen Eisenberg

Sharon M Wahl

Robert C Thompson

Original Assignee

Amgen Boulder Inc

Us Health

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-09

Filing date

1995-03-09

Publication date

1996-12-18

1995-03-09 Application filed by Amgen Boulder Inc, Us Health filed Critical Amgen Boulder Inc

1996-12-18 Publication of OA10133A publication Critical patent/OA10133A/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Virology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
AIDS & HIV (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Tropical Medicine & Parasitology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

OA60622A 1992-09-09 1995-03-09 Inhibition of retrovirus infection OA10133A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US94336992A	1992-09-09	1992-09-09

Publications (1)

Publication Number	Publication Date
OA10133A true OA10133A (en)	1996-12-18

Family

ID=25479533

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
OA60622A OA10133A (en)	1992-09-09	1995-03-09	Inhibition of retrovirus infection

Country Status (23)

Country	Link
EP (1)	EP0666755B1 (de)
JP (2)	JP3517238B2 (de)
KR (1)	KR100273620B1 (de)
AT (1)	ATE238062T1 (de)
AU (1)	AU681350B2 (de)
CA (1)	CA2141951C (de)
CZ (1)	CZ286953B6 (de)
DE (1)	DE69332904T2 (de)
DK (1)	DK0666755T3 (de)
ES (1)	ES2197153T3 (de)
FI (1)	FI951078A7 (de)
HU (1)	HU218892B (de)
NO (1)	NO315546B1 (de)
NZ (1)	NZ256246A (de)
OA (1)	OA10133A (de)
PL (1)	PL307864A1 (de)
PT (1)	PT666755E (de)
RO (1)	RO116164B1 (de)
RU (1)	RU2126266C1 (de)
SG (1)	SG48115A1 (de)
SK (1)	SK281127B6 (de)
UA (1)	UA41338C2 (de)
WO (1)	WO1994006454A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI963753L (fi) *	1994-03-23	1996-09-20	Tokyo Tanabe Co	Uusi lääke hengitysteiden virustaudin hoitamiseksi
AU6530696A (en) *	1995-07-24	1997-02-18	Tokyo Tanabe Company Limited	Remedy for viral diseases
AU7508196A (en)	1995-11-13	1997-06-05	Gerard Voerman	Anti-viral isolates obtainable from leeches
JP4562290B2 (ja)	1999-05-13	2010-10-13	独立行政法人科学技術振興機構	インテグラーゼｎ−末端領域を標的としたウイルス感染阻害剤
DE10101792B4 (de) *	2001-01-17	2004-03-18	Vivotec Biomedical Technologies Gmbh	Verfahren zum Nachweis von Pankreaskarzinom oder chronischer Pankreatitis und Verwendung von Antikörpern
US8288439B2 (en)	2003-11-04	2012-10-16	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Methods and compositions for the inhibition of HIV-1 replication

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4760130A (en) *	1984-12-06	1988-07-26	Synergen Biologicals, Inc.	Serine protease inhibitors and methods for isolation of same
CA1340877C (en) *	1987-12-28	2000-01-18	Takashi Sugiyama	Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
JP2804979B2 (ja) *	1988-11-28	1998-09-30	日本ケミカルリサーチ株式会社	エイズ治療および阻害剤
CA2007083A1 (en) *	1989-01-09	1990-07-09	Nobuhiko Katunuma	Pharmaceutical use of trypstatin
AU5940090A (en) *	1989-08-16	1991-04-03	Cetus Oncology Corporation	Compositions for the inhibition of protein hormone formation and uses thereof
AU6975591A (en) *	1989-12-18	1991-07-18	Transgene S.A.	Pharmaceutical composition for treating or preventing retroviral infections
GR1001044B (el) *	1991-06-03	1993-04-28	Logothetou Rella Eleni	Μηχανισμός διή?ησης νεοπλασματικών κυττάρων και η χρήση του αναστολέα της Ca2+ -εξαρτώμενης ουδέτερης πρωτεάσης για την παρασκευή φαρμακευτικών αντικαρκινικών συν?έσεων.

1993
- 1993-09-09 HU HU9500682A patent/HU218892B/hu not_active IP Right Cessation
- 1993-09-09 DE DE69332904T patent/DE69332904T2/de not_active Expired - Fee Related
- 1993-09-09 NZ NZ256246A patent/NZ256246A/xx not_active IP Right Cessation
- 1993-09-09 UA UA95048317A patent/UA41338C2/uk unknown
- 1993-09-09 RU RU95109909A patent/RU2126266C1/ru not_active IP Right Cessation
- 1993-09-09 FI FI951078A patent/FI951078A7/fi not_active Application Discontinuation
- 1993-09-09 CZ CZ1995559A patent/CZ286953B6/cs not_active IP Right Cessation
- 1993-09-09 JP JP50816294A patent/JP3517238B2/ja not_active Expired - Fee Related
- 1993-09-09 CA CA002141951A patent/CA2141951C/en not_active Expired - Fee Related
- 1993-09-09 DK DK93921439T patent/DK0666755T3/da active
- 1993-09-09 RO RO95-00493A patent/RO116164B1/ro unknown
- 1993-09-09 WO PCT/US1993/008486 patent/WO1994006454A2/en not_active Ceased
- 1993-09-09 PL PL93307864A patent/PL307864A1/xx unknown
- 1993-09-09 KR KR1019950700929A patent/KR100273620B1/ko not_active Expired - Fee Related
- 1993-09-09 EP EP93921439A patent/EP0666755B1/de not_active Expired - Lifetime
- 1993-09-09 SG SG1996007118A patent/SG48115A1/en unknown
- 1993-09-09 SK SK297-95A patent/SK281127B6/sk unknown
- 1993-09-09 PT PT93921439T patent/PT666755E/pt unknown
- 1993-09-09 ES ES93921439T patent/ES2197153T3/es not_active Expired - Lifetime
- 1993-09-09 AU AU48530/93A patent/AU681350B2/en not_active Ceased
- 1993-09-09 AT AT93921439T patent/ATE238062T1/de not_active IP Right Cessation
1995
- 1995-03-08 NO NO19950897A patent/NO315546B1/no unknown
- 1995-03-09 OA OA60622A patent/OA10133A/en unknown
2003
- 2003-07-07 JP JP2003271629A patent/JP2004002455A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
WO1994006454A3 (en)	1994-08-18
EP0666755B1 (de)	2003-04-23
CZ55995A3 (en)	1996-01-17
CZ286953B6 (en)	2000-08-16
JPH08505042A (ja)	1996-06-04
NZ256246A (en)	1997-08-22
HU9500682D0 (en)	1995-04-28
SG48115A1 (en)	1998-04-17
DE69332904D1 (de)	2003-05-28
KR100273620B1 (ko)	2000-12-15
SK29795A3 (en)	1997-02-05
ES2197153T3 (es)	2004-01-01
SK281127B6 (sk)	2000-12-11
RU95109909A (ru)	1997-03-27
PT666755E (pt)	2003-09-30
CA2141951A1 (en)	1994-03-31
FI951078L (fi)	1995-03-08
DK0666755T3 (da)	2003-08-04
UA41338C2 (uk)	2001-09-17
NO950897L (no)	1995-03-08
RO116164B1 (ro)	2000-11-30
NO950897D0 (no)	1995-03-08
JP3517238B2 (ja)	2004-04-12
AU681350B2 (en)	1997-08-28
RU2126266C1 (ru)	1999-02-20
NO315546B1 (no)	2003-09-22
EP0666755A1 (de)	1995-08-16
FI951078A0 (fi)	1995-03-08
JP2004002455A (ja)	2004-01-08
AU4853093A (en)	1994-04-12
DE69332904T2 (de)	2003-11-06
ATE238062T1 (de)	2003-05-15
WO1994006454A2 (en)	1994-03-31
FI951078A7 (fi)	1995-03-08
HU218892B (hu)	2000-12-28
HUT75126A (en)	1997-04-28
PL307864A1 (en)	1995-06-26
CA2141951C (en)	2007-04-24
KR950703357A (ko)	1995-09-20

Publication	Publication Date	Title
Sarin et al.	1987	Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone
US5756449A (en)	1998-05-26	Peptide T and related peptides in the treatment of inflammation, including inflammatory bowel disease
KR19990082084A (ko)	1999-11-15	인터페론으로 선행치료한 hcv 환자를 재치료하기 위한 제약학적 조성물
JPH11507632A (ja)	1999-07-06	併用療法を用いたｈｉｖおよび他のウイルス感染の治療
WO1995017899A2 (en)	1995-07-06	Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
US6017880A (en)	2000-01-25	Inhibition of retrovirus infection
OA10133A (en)	1996-12-18	Inhibition of retrovirus infection
JPH07267874A (ja)	1995-10-17	Ｈｉｖ感染に対する組合せ化学療法
US6869925B1 (en)	2005-03-22	Inhibition of retrovirus infection
RU2290197C2 (ru)	2006-12-27	Фармацевтическое средство для лечения вич-инфекции, содержащая его композиция и способы его применения
EP0960886A1 (de)	1999-12-01	T-peptid und damit verwandte Peptide in der Behandlung von entzündungen einschlies slich der Multiplen Sklerose
JPH10251159A (ja)	1998-09-22	Ｉｌ−６を含む血清尿酸値低下剤
EP1497323B1 (de)	2009-01-21	Mehrfach verzweigte peptidkonstruktion mit 2 bis 16 verzweigungen des peptids rqgys oder 8 bis 16 verzweigungen des peptids rqgy aus dem hiv gp41 glycoprotein
AU763289B2 (en)	2003-07-17	Use of GM-CSF to inhibit development of drug resistance in HIV+ patients
WO2000045833A1 (en)	2000-08-10	Hiv drug resistance system
Pomerantz et al.	1987	Therapy of human immunodeficiency virus infections
Sarin et al.	1987	Lymphadenopathy-Associated Virus) by
EP0696202A1 (de)	1996-02-14	Kombinationspräparat, das thymoctonan und azt enthält
HU203971B (en)	1991-11-28	Process for producing synergetic combination pharmaceutical compositions comprising 3'-azido-3'-deoxythymidine and one more active ingredient
JPWO1998051295A1 (ja)	1999-10-05	Ｈｉｖ−１プロテアーゼ阻害剤、その製造方法及び医薬組成物